MEDP
Medpace Holdings
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: MEDP
- PEG Ratio
Based on the latest data from Jun 3, 2026, MEDP's PE to growth ratio sits at 1.38. This metric combines a PE of 27.79 with an earnings growth rate of 20.1%. Relative to the 1.41 average from the past four quarters, the PEG ratio is down by 2.1%.
MEDP PEG ratio history
Looking at the past ten years, MEDP's PEG ratio has has been around 0.8 on average. At 1.38, today's PEG ratio sits 73% more than its historical average. Within the past ten years, the Dec 2025 quarter saw the highest PEG reading at 1.81. At 0.02, the Jun 2017 quarter represented the lowest PEG ratio in this timeframe.
Medpace Holdings PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 1.81 | 35.91 | 19.8% |
| 2024 | 0.61 | 25.44 | 42% |
| 2023 | 1.55 | 33.32 | 21.5% |
| 2022 | 0.57 | 28.06 | 49.6% |
| 2021 | 1.77 | 43.01 | 24.3% |
| 2020 | 0.75 | 34.2 | 45.9% |
| 2019 | 0.83 | 30.13 | 36.1% |
| 2018 | 0.25 | 25.82 | 105% |
| 2017 | 0.22 | 36.26 | 163.2% |
| 2016 | 0.4 | 94.92 | 235.7% |
| 2015 | N/A | N/A | N/A |
Medpace Holdings PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 1.47 | 29.6 | 20.1% |
| Dec 2025 | 1.81 | 35.91 | 19.8% |
| Sep 2025 | 1.47 | 35.07 | 23.9% |
| Jun 2025 | 0.89 | 22.71 | 25.4% |
| Mar 2025 | 0.69 | 22.55 | 32.8% |
| Dec 2024 | 0.61 | 25.44 | 42% |
| Sep 2024 | 0.83 | 28.22 | 34% |
| Jun 2024 | 1.37 | 37.37 | 27.3% |
| Mar 2024 | 1.64 | 39.74 | 24.3% |
| Dec 2023 | 1.55 | 33.32 | 21.5% |
| Sep 2023 | 0.91 | 27.42 | 30% |
| Jun 2023 | 0.63 | 27.73 | 44.1% |
| Mar 2023 | 0.5 | 22.99 | 46.1% |
| Dec 2022 | 0.57 | 28.06 | 49.6% |
| Sep 2022 | 0.7 | 23.15 | 33.1% |
MEDP average PEG ratio chart
When comparing to historical data, MEDP's PEG ratio sits above the 3 and 5-year averages.
PEG comparison
Medpace Holdings's PEG of 1.38 is higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.55, Medpace Holdings's PEG is 151% higher.
MEDP EPS growth
MEDP Price vs fair value
MEDP PEG vs peers
Relative to its peer stocks OMER and ORMP, MEDP's PEG ratio is higher.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 0 | $156.34M |
| VIVS VivoSim Labs Inc. | 0.01 | $3.49M |
| OMER Omeros Corp | 0.05 | $741.12M |
| MEDP Medpace Holdings Inc | 1.41 | $13.1B |
| OLMA Olema Pharmaceuticals Inc | N/A | $931.12M |
| ORIC Oric Pharmaceuticals Inc | N/A | $830.21M |
Frequently asked questions
What is Medpace Holdings's PEG ratio?
According to Jun 3, 2026 figures, MEDP's PEG ratio stands at 1.38.
What is the 3-year average PEG ratio for Medpace Holdings (MEDP)?
MEDP has a 3-year average PEG ratio of 1.16.
What is the 5-year average PEG ratio for Medpace Holdings (MEDP)?
MEDP has a 5-year average PEG ratio of 1.05.
What is the highest PEG ratio for MEDP?
MEDP's PEG ratio topped out at 1.81 during the Dec 2025 quarter - the highest in ten years.
How does the current PEG ratio for MEDP compare to its historical average?
MEDP currently has a PEG ratio 73% above its 10-year average.
How is MEDP's PEG ratio calculated (Medpace Holdings PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its earnings per share growth (YoY TTM). As of Jun 3, 2026, Medpace Holdings has a PE ratio of 27.79. Earnings grew at 20.1% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 1.38. PEG RATIO(1.38) = PE RATIO(27.79) / EPS GROWTH(20.1%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.